NewLink Genetics Corp Ovarian Cancer Abstract Out Earlynlg207 Is A Potentially Best-In-Class Topoisomerase 1 Inhibitor With Demonstrated Antitumor Activity In Recurrent Ovarian Cancer Including Those Who Have Become Resistant To Platinum